We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
- Authors
Brain, E; Isambert, N; Dalenc, F; Diéras, V; Bonneterre, J; Rezai, K; Jimenez, M; Mefti-Lacheraf, F; Cottura, E; Tresca, P; Vanlemmens, L; Mahier-Aït Oukhatar, C; Lokiec, F; Fumoleau, P
- Abstract
To determine the recommended doses of lapatinib (LPT) combined with vinorelbine (VNR) in women with human epidermal growth factor receptor 2-overexpressing advanced breast cancer pretreated with trastuzumab.
- Publication
British journal of cancer, 2012, Vol 106, Issue 4, p673
- ISSN
1532-1827
- Publication type
Journal Article
- DOI
10.1038/bjc.2011.591